Generative AI Simplifies Echocardiogram Results

A study by clinicians at NYU Langone Health found that a GPT4-based system (the technology behind ChatGPT) can be used to explain echocardiogram (echo) results to patients. The system analyzes doctor-written reports on a common type of echo test and generates human-friendly explanations of test results. There are many implications of this study including the reduction of clinician workload and fast and accurate explanation of test results to patients. JACC: Cardiovascular Imaging

Gen AI Engineers New Antibiotics

Scientists at The University of Texas at Austin have leveraged a Generative AI model to develop a new antibiotic based on an existing antibiotic called Protegrin-1, which is toxic to humans. This new antibiotic is already showing promise in preclinical trials. The model creates potent antimicrobial peptides that have reduced toxicity to mammalian membranes. Potential applications include designing new synthetic classes of antibiotics, especially for resistant bacteria. Nature

1. As reported in the July 2024 GenAI Biotech Report, Gen AI news continues to be dominated by collaborations and partnerships between tech companies with biotech, pharma, and healthcare companies to innovate solutions:

   1. Kaiser Permanente rolls out a Generative AI-based clinical listening and documentation tool powered by Abridge AI technology, which summarizes relevant medical information from spoken, natural conversations between clinicians and patients. Kaiser

   2. Absci collaborates with Memorial Sloan Kettering Cancer Center to discover novel therapeutics using Generative AI. Globe Newswire

   3. Ochsner Health and DeepScribe announce partnership to implement the latter’s AI clinical documentation technology across the former’s hospitals, health and urgent care centers. Ochsner Health

2. The FDA has announced members of it’s new Digital Health Advisory Committee and they will be discussing the use of Generative AI in medical devices this November. FDA

3. Biomatter raises €6.5 million to use Generative AI for enzyme design. Biomatter

4. Pfizer hires a new AI Chief: Berta Rodriguez-Hervas. This is likely the first appointment for this type of role in the pharmaceutical industry. LinkedIn

Sign up here for The GenAI Biotech Report: Your monthly update of Generative AI applications in Biotech, Pharma, and Life Sciences

Catch up on previous monthly updates of The GenAI Biotech Report.